. 2016 Jun 23;12(2):1519–1524. doi: 10.3892/ol.2016.4774

Table I.

TIM-3 expression and clinicopathological factors.

		TIM-3, n

Factor	n	Negative	Positive	P-value
Age, years				0.79
≥65	29	17	12
<65	29	16	13
Gender				0.15
Male	34	22	12
Female	24	11	13
Stage^a				0.66
I, II, III	24	15	9
IV	30	17	13
Response to chemotherapy^a				0.015
Partial/complete	38	24	14
No response	10	2	8
Leukemic change^a				0.46
Yes	29	15	14
No	26	16	10

Data was not available for all patients. Data were statistically analyzed by the χ² test. TIM-3, T cell Ig and mucin domain-containing molecule-3; N.S., not significant.